Exceptional cannabis doesn’t just miraculously appear. Many materials and resources must be successfully manipulated before a top-shelf cannabis product can be harvested or manufactured. Nature must be nurtured. Yet, one of the most significant factors that will determine a cannabis plant’s quality (and therefore its value) is its genetics. 

Ergonomics and the associated employer requirements to maintain safe workplaces, especially in industries where repetitive motion injuries are common, are at the forefront of modern claim prevention. However, the legal cannabis industry could be especially vulnerable.

As a legalization shift sweeps the nation, responsible cannabis growers in California are uniquely positioned to lead the way, while others either comply or face hefty penalties.

As any marijuana stock investor can tell you, the past 15 months haven't been pretty for pot stocks. Since April 2019, the vast majority of cannabis stocks have lost 50% or more of their value as growing pains have taken shape. In Canada, supply issues have led to everything from shortages to bottlenecks. Meanwhile, high tax rates on legal product in the U.S. have ensured that black market demand remains robust.

The COVID-19 outbreak has had a significant impact on the global economy and many countries are still dealing with major outbreaks.

The US is the epicenter of COVID and has the highest number of confirmed cases in the world. Unfortunately, the trend seems to be getting worse and we are closely following how the government handles the outbreak.

Although Canada is one of the countries that seems to have the COVID crisis under control, many companies are still being impacted by the virus. Canopy Growth Corporation (WEED.TO) (CGC) is a leading cannabis producer and it recently announced that an employee at its Ontario facility has tested positive for the virus.

A Canopy Growth employee at the company’s Smiths Falls, Ont. facility has tested positive for COVID-19.

The B.C. government has relieved one regulatory burden from recreational marijuana stores, and imposed another one.

After hundreds of cannabis retailers frosted or masked windows under license terms the province imposed in late 2018, Attorney General David Eby announced June 18 that “non-transparent walls” are no longer required. The change applies to private retailers and government-owned BC Cannabis stores, which used frosted glass.

So, there you are, pondering your finances, there are many expenses and costs that go into running your business and when your budget is already tight, should you add or increase training to the expense list? Why frustrate yourself, looking for ways to train people, when you could be focusing on things like technology, product development or sales that help with business growth?

We all know that product development and sales are important. But what differentiates training from other expenses is that while on the surface training might appear as an expense, it’s not.

If you’ve ever considered making the leap from the mainstream workforce to a career in cannabis, you’re not alone. In 2019, the cannabis industry added 33,700 new jobs, up 15% from the year prior. And this growth came despite shakeups caused by capital dry-ups, the vaping crisis, and more. Since the onset of COVID-19 this year, Vangst has seen thousands of new job seekers join our community – many of whom are readier than every to trade up from their old career for new opportunity in a recession-resistant industry. Cannabis is here to stay, and the most pioneering and innovative professionals are quickly recognizing the upside of getting involved.

Canopy Rivers Inc. (OTC: CNPOF) is laying off employees and cutting back on spending as the company focuses on positive cash flow. The venture capital firm that specializes in cannabis companies said that it is streamlining its operations to preserve its cash on hand.

However, Canopy Rivers said it is still planning on repurchasing some of its subordinated voting shares and that is can buy up to 10% of these shares. The stock was lately trading at $1.02 per share.

A licenced cannabis greenhouse in Leamington, employing about 120 people will be shutting down operations over the next six weeks.

Tilray, Inc. the owner of High Park Gardens announced Wednesday it would be closing its Leamington operation. The company says the closure is expected to yield $7.5 million in annualized net savings.

“We are continuously evaluating the evolving needs of our business, against a challenging industry backdrop, to ensure we’re in the best position to produce world-class products and deliver positive results for our stakeholders,” Brendan Kennedy, Tilray CEO said in a statement.